Guerbet S. A. (GBT) - Net Assets
Based on the latest financial reports, Guerbet S. A. (GBT) has net assets worth €260.08 Million EUR (≈ $304.06 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€930.02 Million ≈ $1.09 Billion USD) and total liabilities (€669.94 Million ≈ $783.23 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Guerbet S. A. (GBT) strategic asset index to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €260.08 Million |
| % of Total Assets | 27.96% |
| Annual Growth Rate | 3.74% |
| 5-Year Change | -35.8% |
| 10-Year Change | -17.38% |
| Growth Volatility | 10.1 |
Guerbet S. A. - Net Assets Trend (2004–2025)
This chart illustrates how Guerbet S. A.'s net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see market value of Guerbet S. A..
Annual Net Assets for Guerbet S. A. (2004–2025)
The table below shows the annual net assets of Guerbet S. A. from 2004 to 2025. Also explore Guerbet S. A. net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €260.08 Million ≈ $304.06 Million |
-33.58% |
| 2024-12-31 | €391.57 Million ≈ $457.79 Million |
+3.52% |
| 2023-12-31 | €378.27 Million ≈ $442.24 Million |
-0.34% |
| 2022-12-31 | €379.57 Million ≈ $443.76 Million |
-6.30% |
| 2021-12-31 | €405.09 Million ≈ $473.60 Million |
+10.15% |
| 2020-12-31 | €367.75 Million ≈ $429.94 Million |
-5.51% |
| 2019-12-31 | €389.19 Million ≈ $455.01 Million |
+6.12% |
| 2018-12-31 | €366.76 Million ≈ $428.78 Million |
+7.20% |
| 2017-12-31 | €342.14 Million ≈ $400.00 Million |
+8.69% |
| 2016-12-31 | €314.80 Million ≈ $368.03 Million |
+11.46% |
| 2015-12-31 | €282.44 Million ≈ $330.20 Million |
+9.01% |
| 2014-12-31 | €259.10 Million ≈ $302.92 Million |
+8.75% |
| 2013-12-31 | €238.26 Million ≈ $278.55 Million |
+5.33% |
| 2012-12-31 | €226.21 Million ≈ $264.46 Million |
+5.31% |
| 2011-12-31 | €214.80 Million ≈ $251.12 Million |
+2.03% |
| 2010-12-31 | €210.52 Million ≈ $246.12 Million |
+2.54% |
| 2009-12-31 | €205.31 Million ≈ $240.02 Million |
+10.54% |
| 2008-12-31 | €185.73 Million ≈ $217.13 Million |
+8.64% |
| 2007-12-31 | €170.96 Million ≈ $199.86 Million |
+12.37% |
| 2006-12-31 | €152.14 Million ≈ $177.86 Million |
+7.78% |
| 2005-12-31 | €141.16 Million ≈ $165.03 Million |
+17.43% |
| 2004-12-31 | €120.21 Million ≈ $140.54 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Guerbet S. A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 356.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €12.64 Million | 4.73% |
| Other Comprehensive Income | €286.62 Million | 107.35% |
| Other Components | €11.77 Million | 4.41% |
| Total Equity | €266.99 Million | 100.00% |
Guerbet S. A. Competitors by Market Cap
The table below lists competitors of Guerbet S. A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shinsegae Food
KO:031440
|
$93.47 Million |
|
Papoutsanis S.A
AT:PAP
|
$93.49 Million |
|
Neo Technical System Co. Ltd
KQ:085910
|
$93.50 Million |
|
Cardiff Oncology Inc
NASDAQ:CRDF
|
$93.66 Million |
|
Phoenix Group Holdings PLC
LSE:PHNX
|
$93.45 Million |
|
Cheryong Industrial Co.Ltd
KQ:147830
|
$93.45 Million |
|
Getty Images Holdings Inc.
NYSE:GETY
|
$93.43 Million |
|
Cemacon Zalau
RO:CEON
|
$93.42 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Guerbet S. A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 394,237,000 to 266,994,000, a change of -127,243,000 (-32.3%).
- Net loss of 108,331,000 reduced equity.
- Other comprehensive income decreased equity by 30,744,000.
- Other factors increased equity by 11,832,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-108.33 Million | -40.57% |
| Other Comprehensive Income | €-30.74 Million | -11.51% |
| Other Changes | €11.83 Million | +4.43% |
| Total Change | €- | -32.28% |
Book Value vs Market Value Analysis
This analysis compares Guerbet S. A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.35x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.74x to 0.35x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | €10.00 | €7.40 | x |
| 2005-12-31 | €11.24 | €7.40 | x |
| 2006-12-31 | €12.13 | €7.40 | x |
| 2007-12-31 | €13.61 | €7.40 | x |
| 2008-12-31 | €14.89 | €7.40 | x |
| 2009-12-31 | €16.35 | €7.40 | x |
| 2010-12-31 | €16.86 | €7.40 | x |
| 2011-12-31 | €16.47 | €7.40 | x |
| 2012-12-31 | €17.75 | €7.40 | x |
| 2013-12-31 | €18.73 | €7.40 | x |
| 2014-12-31 | €20.41 | €7.40 | x |
| 2015-12-31 | €22.52 | €7.40 | x |
| 2016-12-31 | €24.85 | €7.40 | x |
| 2017-12-31 | €27.01 | €7.40 | x |
| 2018-12-31 | €28.96 | €7.40 | x |
| 2019-12-31 | €30.73 | €7.40 | x |
| 2020-12-31 | €29.04 | €7.40 | x |
| 2021-12-31 | €32.05 | €7.40 | x |
| 2022-12-31 | €30.08 | €7.40 | x |
| 2023-12-31 | €30.08 | €7.40 | x |
| 2024-12-31 | €31.28 | €7.40 | x |
| 2025-12-31 | €21.15 | €7.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Guerbet S. A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -40.57%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -13.78%
- • Asset Turnover: 0.85x
- • Equity Multiplier: 3.48x
- Recent ROE (-40.57%) is below the historical average (6.75%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 14.31% | 6.95% | 0.97x | 2.13x | €5.18 Million |
| 2005 | 16.30% | 8.54% | 0.91x | 2.10x | €8.90 Million |
| 2006 | 12.44% | 6.54% | 0.89x | 2.15x | €3.71 Million |
| 2007 | 13.90% | 7.78% | 0.86x | 2.09x | €6.67 Million |
| 2008 | 13.13% | 7.60% | 0.84x | 2.06x | €5.82 Million |
| 2009 | 9.98% | 6.11% | 0.85x | 1.92x | €-35.60K |
| 2010 | 2.79% | 1.67% | 0.84x | 2.00x | €-15.17 Million |
| 2011 | 6.72% | 3.82% | 0.84x | 2.09x | €-7.05 Million |
| 2012 | 9.02% | 5.05% | 0.88x | 2.04x | €-2.22 Million |
| 2013 | 8.60% | 5.25% | 0.85x | 1.93x | €-3.34 Million |
| 2014 | 10.08% | 6.38% | 0.86x | 1.84x | €216.60K |
| 2015 | 14.14% | 8.15% | 0.54x | 3.20x | €11.68 Million |
| 2016 | 9.19% | 3.73% | 0.76x | 3.27x | €-2.55 Million |
| 2017 | 13.51% | 5.72% | 0.85x | 2.79x | €12.00 Million |
| 2018 | 12.77% | 5.89% | 0.74x | 2.95x | €10.14 Million |
| 2019 | 9.59% | 4.57% | 0.81x | 2.59x | €-1.59 Million |
| 2020 | 4.96% | 2.56% | 0.75x | 2.57x | €-18.54 Million |
| 2021 | 8.06% | 4.43% | 0.74x | 2.47x | €-7.87 Million |
| 2022 | -10.83% | -5.34% | 0.82x | 2.48x | €-79.07 Million |
| 2023 | 6.31% | 3.00% | 0.78x | 2.71x | €-13.97 Million |
| 2024 | 4.08% | 1.89% | 0.82x | 2.63x | €-23.34 Million |
| 2025 | -40.57% | -13.78% | 0.85x | 3.48x | €-135.03 Million |
Industry Comparison
This section compares Guerbet S. A.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $27,912,041
- Average return on equity (ROE) among peers: -36.72%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Guerbet S. A. (GBT) | €260.08 Million | 14.31% | 2.58x | $93.47 Million |
| Affluent Medical SAS (AFME) | $58.87 Million | -9.92% | 0.05x | $110.43 Million |
| Biosynex (ALBIO) | $80.50 Million | -53.79% | 1.42x | $15.74 Million |
| Bluelinea SA (ALBLU) | $2.22 Million | -16.40% | 0.58x | $3.21 Million |
| Carmat (ALCAR) | $7.76 Million | -235.22% | 0.81x | $6.37 Million |
| Diagnostic Medical Systems SA (ALDMS) | $17.05 Million | -30.74% | 1.69x | $33.03 Million |
| Eurobio Scientific SA (ALERS) | $36.56 Million | 8.62% | 1.22x | $236.10 Million |
| Ikonisys SA (ALIKO) | $15.73 Million | -14.41% | 0.33x | $21.30 Million |
| Implanet SA (ALIMP) | $8.86 Million | 0.00% | 0.89x | $28.16 Million |
| Mediantechn (ALMDT) | $0.00 | 0.00% | 0.00x | $176.64 Million |
| Mauna Kea Technologies SAS (ALMKT) | $51.57 Million | -15.38% | 0.17x | $28.43 Million |
About Guerbet S. A.
Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide. It offers DOTAREM, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced MRI examinations; Elucirem, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced resonance imaging; UNIK, a diagnostic imaging interconne… Read more